Big Picture News, Informed Analysis

Canadian journalist Donna Laframboise. Former National Post & Toronto Star columnist, past vice president of the Canadian Civil Liberties Association.

200 Published Reports of Vaccine Linked Medical Problems

COVID vaccines are linked to inflammation of the brain & spinal cord. They’re linked to blood clots, strokes, heart problems, liver problems, vision problems, facial paralysis & skin disorders (includes photos).

Part 1: Introductory remarks and the first 100 medical reports (click)

Medical complications that develop after COVID-19 vaccination have been extensively documented in peer reviewed medical journals. From Israel to Japan, from Spain to Australia, these complications are often life-altering.

Here’s the second batch of 100 published papers (I’m working from a list of 400+ catalogued by someone else). I’ve numbered these and have updated most of the hyperlinks to point directly to the full paper, rather than to an abstract.

Comments in red added by me.

101. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: [blood clots, British Medical Journal, Aug. 2021]

102. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after covid-19 vaccination; a systematic review: [blood clots, Journal of the Neurological Sciences, Aug. 2021]

103. Nerve and muscle adverse events after vaccination with COVID-19: a systematic review and meta-analysis of clinical trials: [nerve & muscle problems, Vaccines, Aug. 2021]

104. A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine: [stroke, Journal of Personalized Medicine, Apr. 2021]

105. Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): [blood clots, European Journal of Internal Medicine, July 2021]

106. Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: [stroke, QJM: An International Journal of Medicine, July 2021]

107. Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccine: [blood clots, Intensive Care Medicine, June 2021]

108. 59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism 7 days after a first dose of Pfizer-BioNTech BNT162b2 mRNA vaccine COVID-19: [stroke, American Journal of Case Reports, June 2021]

109. Cerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience: [stroke, Anaesthesia Critical Care & Pain Medicine, Aug. 2021]

Bell’s palsy (facial paralysis). 9 days after this 50-year-old Spanish man received his first dose of Pfizer COVID vaccine, he experienced difficulty drinking fluids due to this condition. Click image to enlarge. Photo source HERE (#132 on this list)

110. Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines: [heart inflammation, Cureus, June 2021]

111. Pericarditis after administration of COVID-19 mRNA BNT162b2 vaccine: [heart inflammation, Revista Española de Cardiología, Spanish Society of Cardiology, Dec. 2021]

112. Unusual presentation of acute pericarditis after vaccination against SARS-COV-2 mRNA-1237 Moderna: [heart inflammation, Cureus, July 2021]

113. Case report: acute myocarditis after second dose of SARS-CoV-2 mRNA-1273 vaccine mRNA-1273: [heart inflammation, European Heart Journal: Case Reports, Aug. 2021]

114. Immune-mediated disease outbreaks or recent-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: [immune disorder, Vaccines, Apr. 2021]

115. Insights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine: could accidental intravenous injection of a vaccine induce myopericarditis: [heart inflammation, Clinical Infectious Diseases, Aug. 2021]

116. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine: [blood clots, American Journal of Hematology, Jan. 2021]

117. Propylthiouracil-induced neutrophil anti-cytoplasmic antibody-associated vasculitis after COVID-19 vaccination: [blood vessel inflammation, Vaccines, July 2021]  JAPAN

118. Secondary immune thrombocytopenia (ITP) associated with ChAdOx1 Covid-19 vaccine: case report: [blood clots, TH: Open, July 2021] GERMANY

119. Thrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination: risk-benefit analysis for persons <60 years in Australia: [blood clots, Vaccine, Aug. 2021] AUSTRALIA

click to enlarge; photo source HERE (#165 on this list)

120. COVID-19 vaccination association and facial nerve palsy: A case-control study: [Bell’s palsy, JAMA Otolaryngol Head Neck Surgery, June 2021]

121. The association between COVID-19 vaccination and Bell’s palsy: [Bell’s palsy, Lancet, Aug. 2021]

122. Bell’s palsy after COVID-19 vaccination: [Bell’s palsy, Journal of Neurology, Feb. 2021]

123. Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 vaccine (AZD1222): [spinal cord inflammation, Frontiers in Immunology, Apr. 2021] PANAMA

124. Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 mRNA-1273 vaccine: [Bell’s palsy, Cureus, June 2021]

125. Sequential contralateral facial nerve palsy after first and second doses of COVID-19 vaccine: [Bell’s palsy, British Medical Journal Case Reports, July 2021]

126. Transverse myelitis induced by SARS-CoV-2 vaccination: [spinal cord inflammation, Cureus, July 2021]

127. Peripheral facial nerve palsy after vaccination with BNT162b2 (COVID-19): [Bell’s palsy, Israel Medical Association Journal, Mar. 2021]  ISRAEL 9 patients

128. Acute abducens nerve palsy after COVID-19 vaccination: [vision problems, Journal of the American Association for Pediatric Ophthalmology and Strabismus, Oct. 2021]

129. Facial nerve palsy after administration of COVID-19 mRNA vaccines: analysis of self-report database: [Bell’s palsy, International Journal of Infectious Diseases, Sept. 2021]

Lesions on wrist. Photo source HERE (#174 on this list)

130. Transient oculomotor paralysis after administration of RNA-1273 messenger vaccine for SARS-CoV-2 diplopia after COVID-19 vaccine: [vision problems, Journal of Neuro-Ophthalmology, Aug. 2021]

131. Bell’s palsy after Ad26.COV2.S COVID-19 vaccination: [Bell’s palsy, QJM: An International Journal of Medicine, Sept. 2021]

132. Bell’s palsy after COVID-19 vaccination: case report: [Bell’s palsy, Neurologia, Spanish Neurology Society, Sept. 2021]

133. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy following ChAdOx1 nCoV-19 vaccination: [nerve damage, Neurological Sciences, July 2021]

134. Guillian Barré syndrome following mRNA-1273-COVID-19 vaccine: [nerve damage, Journal of the Danish Medical Association, Aug. 2021]

135. Acute facial paralysis as a possible complication of SARS-CoV-2 vaccination: [Bell’s palsy, Laryngorhino-otology, May 2021]

136. Bell’s palsy after COVID-19 vaccination with high antibody response in CSF: [Bell’s palsy, Neurological Sciences, July 2021]

137. Parsonage-Turner syndrome associated with SARS-CoV-2 or SARS-CoV-2 vaccination. Comment on: “Neuralgic amyotrophy and COVID-19 infection: 2 cases of accessory spinal nerve palsy”: [nerve damage, Joint Bone Spine, Dec. 2021]

138. Bell’s palsy after a single dose of vaccine mRNA. SARS-CoV-2: case report: [Bell’s palsy, Journal of Neurology, May 2021]

139. Autoimmune hepatitis developing after coronavirus disease vaccine 2019 (COVID-19): causality or victim? [liver problems, Journal of Hepatology, Apr. 2021]

140. Autoimmune hepatitis triggered by vaccination against SARS-CoV-2: [liver problems, 2021]

141. Acute autoimmune-like hepatitis with atypical antimitochondrial antibody after vaccination with COVID-19 mRNA: a new clinical entity: [liver problems, Journal of Autoimmunity, Sept. 2021]

142. Autoimmune hepatitis after COVID vaccine: [liver problems, Journal of Autoimmunity, Sept. 2021]

143. A novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19: [nerve damage, Neurology International, Aug. 2021]

144. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: [blood clots, Journal of Autoimmunity, Aug. 2021]

145. Bilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: [blood clots, Lancet, Apr. 2021]

146. Diagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia: [stroke, Stroke, Apr. 2021]

147. Venous sinus thrombosis after vaccination with ChAdOx1 nCov-19: [stroke, Medicina Intensive, Spanish Society of Intensive Care Medicine and Coronary Units, Aug. 2021]

148. Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: [stroke, European Journal of Neurology, July. 2021]

149. COVID-19 mRNA vaccine causing CNS inflammation: a case series: [blood vessel inflammation, Journal of Neurology, Sept. 2021]

150. Thymic hyperplasia after Covid-19 mRNA-based vaccination with Covid-19: [immune system problems, Radiology Case Reports, Dec. 2021]

151. Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2: [brain inflammation, Clinical Neurology and Neurosurgery, Sept. 2021]

152. Tolosa-Hunt syndrome occurring after COVID-19 vaccination: [vision problems, Cureus, July 2021]

153. Systemic capillary extravasation syndrome following vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca): [immune disorder, Canadian Medical Association Journal, Aug. 2021]

154. Immune-mediated thrombocytopenia associated with Ad26.COV2.S vaccine (Janssen; Johnson & Johnson): [blood clots, American Journal of Therapeutics, Sept-Oct. 2021]

155. Transient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad26.COV2.S: case report: [blood clots, Annals of Internal Medicine, Nov.2021]

156. Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: case report: [brain disorder, Annals of Medicine and Surgery, Sept. 2021]

157. Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine: [heart inflammation, Pediatric Infectious Disease Journal, Oct. 2021]

158. Autoimmune hepatitis developing after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): [liver problems, Journal of Hepatology, June 2021]

159.Severe relapse of multiple sclerosis after COVID-19 vaccination: a case report: [multiple sclerosis relapse, Frontiers in Neurology, Aug. 2021]

160. DUPLICATE of #74 HERE Lymphohistocytic myocarditis after vaccination with the COVID-19 viral vector Ad26.COV2.S: [heart inflammation, International Journal of Cardiology: Heart & Vasculature, Oct. 2021]

161. Hemophagocytic lymphohistiocytosis after vaccination with ChAdOx1 nCov-19: [immune disorder, Journal of Medical Virology, Aug. 2021]

162. IgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19: [blood vessel inflammation, Autoimmunity Reviews, Nov. 2021]

163. A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report: [blood vessel inflammation, Arthritis & Rheumatology, July 2021]

164. Onset / outbreak of psoriasis after Corona virus ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca / Covishield): report of two cases: [skin problems, Dermatologic Therapy, Aug. 2021]

165. Hailey-Hailey disease exacerbation after SARS-CoV-2 vaccination: [skin problems, Advances in Dermatology and Venereology, Aug. 2021]: [backed up here]

166. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: [lymph node inflammation, Clinical Imaging, June 2021]

167. COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern in cases with underlying hepatic problems: [blood clots, Annals of Hepatology, Sept-Oct. 2021]

168. Report of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-2 vaccination: [stroke, European Journal of Neurology, Aug. 2021]

169. Immune thrombocytopenia after vaccination during the COVID-19 pandemic: [blood clots, Haematologica, Aug. 2021]

170. COVID-19: lessons from the Norwegian tragedy should be taken into account in planning for vaccine launch in less developed/developing countries: [sudden death, Open Medicine, Aug. 2021]

171. Rituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19: [drug interactions, Clinical Case Reports, Aug. 2021]

172. Exacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b2 vaccines: report of two cases: [skin problems, Dermatologic Therapy, Aug. 2021]

173. Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccine: [lung disease, Thorax, Jan. 2022]

174. Vesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature: [skin problems, Clinical and Experimental Dermatology, July 2021]

175. Vaccine-induced thrombocytopenia with severe headache: [blood clots, New England Journal of Medicine, Nov. 2021]

176. Acute perimyocarditis after the first dose of COVID-19 mRNA vaccine: [heart inflammation, Deutsches Ärzteblatt International, 2021]

177. Rhabdomyolysis and fasciitis induced by COVID-19 mRNA vaccine: [muscle problems, Journal of Neurology, Aug. 2021]

178. Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature: [skin problems, Journal of the European Academy of Dermatology and Venereology, Aug. 2021]

179. Immune thrombocytopenia associated with the Pfizer-BioNTech COVID-19 mRNA vaccine BNT162b2: [blood clots, Infectious Disease Cases, 2021]

180. Secondary immune thrombocytopenia putatively attributable to COVID-19 vaccination: [blood clots, BMJ Case Reports, May 2021]

181. Immune thrombocytopenia following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: [blood clots, Israel Medical Association Journal, June 2021]:

182. Newly diagnosed idiopathic thrombocytopenia after COVID-19 vaccine administration: [blood clots, Cureus, May 2021]

183. Idiopathic thrombocytopenic purpura and the Modern Covid-19 vaccine: [blood clots, Annals of Emergency Medicine, Feb. 2021]

184. Thrombocytopenia after Pfizer and Moderna SARS vaccination – CoV -2: [blood clots, American Journal of Hematology, Feb. 2021]

185. Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccination: [blood clots, BMJ Case Reports, July 2021]

186. Collection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-2 vaccination: [immune disorders, Blood Advances, July 2021]

187. Petechial rash associated with CoronaVac vaccination: first report of cutaneous side effects before phase 3 results: [skin problems, European Journal of Hospital Pharmacy, May2021]

188. COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria: [blood disorder, Blood, July 2021]

189. Cerebral venous thrombosis associated with COVID-19 vaccine in Germany: [stroke, Annals of Neurology, July 2021]

190. Cerebral venous sinus thrombosis after COVID-19 vaccination: Neurological and radiological management: [stroke, Der Radiologe, July 2021]

191. Cerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination: [stroke, hrombosis Research, Apr. 2021]

192. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: [stroke, Brain, Behaviour, and Immunity, July 2021]

193. Cerebral venous thrombosis induced by SARS-CoV-2 vaccine: [stroke, European Journal of Internal Medicine, May 2021]

194. Carotid artery immune thrombosis induced by adenovirus-vectored COVID-19 vaccine: case report: [blood clots, Neurology, July 2021]

195. Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia: [stroke, Neuroradiology Journal, Aug. 2021]

196. DUPLICATE of #15 HERE The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia: [blood clots, Trends in Cardiovascular Medicine, Jan. 2022]

197. Cerebral venous thrombosis after the BNT162b2 mRNA SARS-CoV-2 vaccine: [stroke, Journal of Stroke & Cerebrovascular Diseases, May 2021]

198. Cerebral venous thrombosis after COVID-19 vaccination: [stroke, Journal of Stroke & Cerebrovascular Diseases, May 2021]

199. Lethal cerebral venous sinus thrombosis after COVID-19 vaccination: [fatal stroke, Intensive Care Medicine, May 2021]

200. DUPLICATE of #41 HERE Cerebral venous sinus thrombosis in the U.S. population, After SARS-CoV-2 vaccination with adenovirus and after COVID-19: [stroke, Journal of the American College of Cardiology, July 2021]



This blog isn’t cluttered with intrusive ads –
which means no income is earned in that manner.
If what you’ve just read is useful or helpful,
please consider making a donation

please support this blog






Print Friendly, PDF & Email


This entry was posted on January 19, 2022 by in ethical & philosophical, health and tagged .
%d bloggers like this: